October 22, 2019
On October 22, representatives from the National Capital Lyme Disease Association (NatCapLyme) along with Lyme advocates from across the country were invited to participate in a briefing sponsored by the Center for Lyme Action on Capitol Hill. The purpose of this briefing was to raise awareness about the growing threat to public health of tick-borne diseases. This event was also the launch of a new national organization dedicated to increasing federal funding for better diagnosis and treatment options for tick-borne diseases.
The Center for Lyme Action, this new nonprofit based in Washington, D.C., will concentrate on lobbying Congress to expand funding for the U.S. Department of Health and Human Services (HHS) to accelerate the development of new drugs and diagnostic tools for Lyme disease.
According to Monte Skall, executive director of NatCapLyme, ” It was truly inspiring to see so many diverse Lyme advocacy groups assembled for the sole purpose of spotlighting the tremendous need to further the development of diagnostics and drugs to alleviate the suffering caused by a tick-borne illness.”